FindTrial
Sign In

The clinical study of acetic acid enhancement with Blue laser imaging in the diagnosis of Gastric Mucosa lesions.

The clinical study of acetic acid enhancement with Blue laser imaging in the diagnosis of Gastric intestinal Metaplasia.

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-DDD-17011370
Enrollment
Unknown
Registered
2017-05-12
Start date
2017-05-12
Completion date
Unknown
Last updated
2017-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intestinal Metaplasia

Interventions

Gold Standard:The histological diagnosis of upper Digestive tract Mucosa lesions is Gold Standard
Index test:acetic&#32
acid,&#32
blue&#32
laser&#32
imaging,&#32
gastroscopy

Sponsors

The Sixth Affiliated Hospital, Sun Yat-sen University.
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 80 Years

Inclusion criteria

Inclusion criteria: Person who were 40 years or older and required endoscopic examination.

Exclusion criteria

Exclusion criteria: Person with noticeable advanced gastric cancer, previous gastrectomy or partial gastric resection, on-going treatment with anticoagulant medication, antiplatelet medication or non-steroidal anti-inflammatory drugs, gastrorrhagia and the presence of hemorrhagic diseases.

Design outcomes

Primary

MeasureTime frame
Percent Agreement Between acetic acid enhanced blue laser imaging Endoscopic Biopsy;—

Countries

China

Contacts

Public ContactHonglei Chen

The Sixth Affiliated Hospital, Sun Yat-sen University

chl_830830@163.com+86 18138728623

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026